5Mannnino DM, Davis KJ. Lung function decline and outcomes in an elderly popuhne. Thorax ,2006,61:472-477.
6Shepherd J,Cobbe SM,Ford I, et al. Prevention of coronary heart disease with pravastation in men with hypercholesterolemia. West of Scotland Coronary Prevention Group. N Engl J Med, 1995,333: 1301-1307.
7Cosio Piqueras MG, Cosio MG. Disease of the airway in chronic obstruction pulmonary disease . Eur Respir J, 2001,18 Suppl :41S- 49S.
8Kanazawa H. Role of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease. Med Sci Monit ,2007,13 : RA189-195.
9KasaharaY,Tuder RM, Cool CD, et al. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growthfactor receptor 2 in emphysema. Am J Respir Crit Care Med,2001,163:737-744.
10Takahashi S, Nakamurea H, Seki M, et al. Reversal of elastase - induced pulmonary emphysema and promotion of alveolar epithelial cell proliferation by simvastatin in mice. Am J Physiol Lung Cell Mol Physiol,2008,294 : L882-L890.
3Carlsen J, Hasseriis Andersen K, Boesgaard S, et al. Pulmonary ar-terial lesions in explanted lungs after transplantation correlate with se- verity of pulmonary hypertension in chronic obstructive pulmonary disease [ J ]. J Heart Lung Transplant, 2013, 32:347 - 354.
4Kosanovic D, Dahal BK, Peters DM, et al. Histological characte- rization of mast cell chymase in patients with pulmonary hypertension and chronic obstructive pulmonary disease[ J]. Pulm Circ, 2014, 4: 128 - 136.
5Noteboom B, Jenkins S, Maiorana A, et al. Comorbidities and medi- cation burden in patients with chronic obstructive pulmonary disease attending pulmonary rehabilitation [ J ]. J Cardiopulm Rehabil Prey, 2014, 34:75-79.
6RABE KF, HURD S,ANZUETO A, etal. Global strategy for the diagnosis,management,and prevention of chronicobstructive pulmonary disease: GOLDexecutive summary [J]. Am J RespirCrit Care Med, 2007,176(6) :532-555.
